MARKET

BASI

BASI

Bioanalyticl Sys
NASDAQ

Real-time Quotes | Nasdaq Last Sale

18.27
+1.23
+7.22%
Closed 19:52 03/01 EST
OPEN
17.18
PREV CLOSE
17.04
HIGH
19.27
LOW
17.13
VOLUME
113.55K
TURNOVER
--
52 WEEK HIGH
19.27
52 WEEK LOW
3.050
MARKET CAP
203.37M
P/E (TTM)
-55.1630
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
The President of Bioanalytical Systems, Inc. (NASDAQ:BASI), Robert Leasure, Just Bought 2.2% More Shares
Whilst it may not be a huge deal, we thought it was good to see that the Bioanalytical Systems, Inc. ( NASDAQ:BASI...
Simply Wall St. · 5d ago
Bioanalytical Systems Says Doing Business As Inotiv, Invests In Laboratory Infrastructure, Data, Study Management Technologies
Bioanalytical Systems, Inc., doing business as Inotiv, Invests in Laboratory Infrastructure and Data and Study Management Technologies WEST LAFAYETTE, Ind., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems,
Benzinga · 5d ago
Bioanalytical Systems, Inc., doing business as Inotiv, Invests in Laboratory Infrastructure and Data and Study Management Technologies
WEST LAFAYETTE, Ind., Feb 24, 2021 (GLOBE NEWSWIRE via COMTEX) -- WEST LAFAYETTE, Ind., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc....
GlobeNewswire · 5d ago
BRIEF-Bioanalytical Systems Files For Mixed Shelf Of Up To $100 Mln
reuters.com · 02/19 21:54
Bioanalytical Systems Files Registration Statement for $100 Million in Securities
MT Newswires · 02/19 16:53
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 17)
Benzinga · 02/18 13:14
Microdialysis Market Growth 2021 CAGR Value, Analysis by Size, Share, Top Key Players, Latest Trends and Forecast to 2024
Feb 18, 2021 (The Expresswire) -- “Microdialysis Market” research report conveys an essential review of the Microdialysis market including its definition,...
The Express Wire · 02/18 08:24
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16)
Benzinga · 02/17 12:26
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BASI. Analyze the recent business situations of Bioanalyticl Sys through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BASI stock price target is 21.00 with a high estimate of 21.00 and a low estimate of 21.00.
EPS
Institutional Holdings
Institutions: 34
Institutional Holdings: 1.85M
% Owned: 16.63%
Shares Outstanding: 11.13M
TypeInstitutionsShares
Increased
1
100.05K
New
10
885.86K
Decreased
4
384.06K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+2.13%
Pharmaceuticals & Medical Research
+1.38%
Key Executives
Chairman/Director
Gregory Davis
Chairman/Chief Executive Officer/Director
Paul Yonamine
President/Chief Executive Officer/Director
Robert Leasure
President/Director
Agnes Ngo
Chief Financial Officer/Vice President - Finance
Beth Taylor
Vice Chairman/Independent Director
Colbert Matsumoto
Chief Financial Officer/Executive Vice President/Treasurer
David Morimoto
Chief Operating Officer
Greg Beattie
Chief Operating Officer
John Beattie
Executive Vice President/Chief Marketing Officer
Kevin Dahlstrom
Chief Human Resource Officer
William Pitchford
Senior Vice President
Michael Baim
Executive Vice President
Blenn Fujimoto
Senior Vice President
Philip Downing
Executive Vice President
David Hudson
Executive Vice President
Arnold Martines
Vice President
Andrew Alexander
Other
Joe Flynn
Lead Director/Independent Director
Crystal Rose
Vice President
I.M. Grossi
Independent Director
Christine Camp
Vice President
Daniel Smeak
Other/Director
John Sagartz
Independent Director
Earl Fry
Independent Director
Wayne Kamitaki
Other
Adam Aulbach
Other
Joseph Flynn
Independent Director
Paul Kosasa
Independent Director
Richard Johnson
Independent Director
Duane Kurisu
Independent Director
R. Matthew Neff
Independent Director
Christopher Lutes
Independent Director
Wendy Perrow
Independent Director
Saedene Ota
  • Dividends
  • Splits
  • Insider Activity
No Data
About BASI
Bioanalytical systems, Inc. is an international contract research company providing drug discovery and development services and analytical instruments. The Company operates in two segments: contract research services and research products. The contract research services segment provides research and development support on a contract basis to pharmaceutical companies. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers, and medical research institutions. The Company supports the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. The contract research services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing.

Webull offers kinds of Bioanalytical Systems, Inc. stock information, including NASDAQ:BASI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BASI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BASI stock methods without spending real money on the virtual paper trading platform.